DiaMedica Therapeutics, Inc.
DiaMedica-Logo
Navigate DiaMedica Therapeutics, Inc.
Home
About Us
Overview
Leadership Team
Board of Directors
Advisors
Pipeline
Pipeline
Lead Product
Chronic Kidney Disease
Acute Ischemic Stroke
Clinical Trials
News
Press Releases
Investors
Investors
IR Overview
News
Press Releases
Email Alerts
Presentations
Presentations
Stock Data (NASDAQ)
Quote
Charts
Historical Data
Stock Data (TSXV)
Quote
Charts
Historical Data
Analyst Coverage
Analyst Coverage
Financials & Filings
SEC Filings
SEDAR Filings
Corporate Governance
Board of Directors
Board Committees
Governance Documents
FAQ
FAQ
Careers
Contact
Home
News
Press Releases
Press Releases
All News
By Year:
2019
2018
2017
2016
Jan 9, 2019
DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange
Jan 3, 2019
DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease